Services (for pharmaceutical companies) to promote the proper use of the latest therapies using DX other than “MRPlus®”

on 11月 24, 2022

Web Lecture

Live delivery of lectures by KOLs

・One of CareNet’s core solutions along with “MRPlus^®”

・A service that provides CareNet member physicians with the live streaming of lectures by expert physicians hosted by pharmaceutical companies.

・We provide early online access to information on new therapies and other information.

・The delivery is handled by a company designated by your company, and CareNet takes care of attracting target physicians/viewing management (verification).

・We can also provide a one-stop service for attracting target physicians, live recording / distribution, and verification.

・We use interactive communication during contents delivery, such as when a speaker answers questions from the audience.

・We provide immediate feedback to pharmaceutical companies on the number of viewers and the responses of the physicians who viewed the contents.

Cancer@Misewaza

Oncology surgery information specialized channel

・CareNet’s own dedicated channel for oncology surgery information.

・A service that provides medical information centered on high-quality surgical videos of experts.

・Experts, which boast top-class results in organ-specific cancer treatment, publish videos of their own treatment methods.

・Editorial board members representing various fields determine performers, review surgical procedures, and provide medical information centered on high-quality surgical videos.

https://misewaza.carenet.com//

(It is in Japanese only)

Medical Gateway

A service that directs CareNet members to the websites and contents of pharmaceutical companies

・A service that directs CareNet members to websites and contents owned by pharmaceutical companies, such as topics related to disease treatment and product information.

・Reduces the preparation and internal screening process by allowing the use of contents already owned by the pharmaceutical company.

Medical Update

A service that distributes drug information to target physicians via e-mail

・Timely distribution of information on drug approvals, product launches, indication expansions, etc., introduction of papers and evidence, information on Web lectures and seminars, and links to product websites, etc., via e-mail.

・Easy templates can be used without creating HTML emails.

・Provides “reporting reports” on open rates, click rate